KDR and cancer: We have synthesized thirteen benzylethoxyaryl ureas and one benzylethoxyaryl carbamate to determine their capability as potential multitarget inhibitors of VEGFR-2 and PD-L1 proteins to overcome resistance phenomena offered by cancer.